1. Food and Drug Administration, Investigational new drug safety reporting requirements for human drug and biological products and safety reporting requirements for bioavailability and bioequivalence studies in humans;US Department of Health and Human Services;Fed. Regist.,2010
2. Food and Drug Administration, Safety Reporting Requirements for INDs and BA/BE Studies, Guidance for Industry and Investigators;US Department of Health and Human Services,2012
3. Safety Assessment for IND Safety Reporting, Draft Guidance for Industry and Investigators;US Department of Health and Human Services, Food and Drug Administration,2015
4. Optimizing expedited safety reporting for drugs and biologics subject to an investigational new drug application;Archdeacon;Ther. Innov. Regul. Sci.,2014
5. A bayesian exposure-time method for clinical trial safety monitoring with blinded data;Schnell;Ther. Innov. Regul. Sci.,2016